Cultures and swabs

It is a gynecological screening test to detect precancerous lesions and cervical cancer, while allowing to confirm or exclude the existence of genital infections caused by Mycoplasma genitalium.

It is a gynecological screening test to detect precancerous lesions and cervical cancer, while also allowing to confirm or exclude the existence of genital infections caused by Chlamydia trachomatis, Ureaplasma sp., Mycoplasma genitalium, M.hominis, HSV, HPV.

It is a gynecological screening test to detect precancerous lesions and cervical cancer, while also allowing to confirm or exclude the existence of genital infections caused by Chlamydia trachomatis, Ureaplasma sp., Mycoplasma genitalium, M.hominis, HPV.

It is a gynecological screening test to detect precancerous lesions and cervical cancer, while also allowing to confirm or exclude the existence of genital infections caused by Chlamydia trachomatis, Ureaplasma sp., Mycoplasma genitalium, M.hominis, HSV.

LBC monolayer cytology + HPV DNA 2 (genotype 6, 11) is a gynecological screening test to detect pre-cancerous lesions and cervical cancer, while allowing to confirm or exclude the existence of genital infection caused by human papilloma virus

LBC monolayer cytology + HPV DNA 2 (genotype 6 and 11) + HSV I/II DNA) is a gynecological screening test to detect pre-cancerous lesions and cervical cancer, while allowing to confirm or exclude the existence of genital infections caused by human papilloma virus and herpes.

LBC monolayer cytology + HPV DNA 14 + HSV I/II DNA is a gynecological screening test to detect pre-cancerous lesions and cervical cancer, while allowing to confirm or exclude the existence of genital infections caused by human papilloma virus and herpes.

It is a gynecological screening test to detect precancerous lesions and cervical cancer, while allowing to confirm or exclude the existence of genital infections caused by Mycoplasma genitalium and Ureaplasma sp.

The LBC + Urogin 2 test is designed for the evaluation of cellsórek in the very early stage of neoplastic lesions and the diagnosis of the most common genitourinary infections, allowing to confirm or exclude the existence of genital infections caused by Chlamydia trachomatis, Mycoplasma genitalium.

The LBC + Urogin 1 test is designed for the evaluation of cellsórek in the very early stage of cancerous lesions and the diagnosis of genitourinary infections, allowing to confirm or exclude the existence of genital infections caused by HPV, Chlamidia trachomatis and Ureaplazma sp.